clinical trials

FDA Report on Enrollment Criteria for Drug Clinical Trials Points to Barriers, Strategies
FDA Report on Enrollment Criteria for Drug Clinical Trials Points to Barriers, Strategies
RAPS.org
FDA
clinical trials
Flag link:
Alpha Tau wins approval to test cancer-targeting device in the U.S.
Alpha Tau wins approval to test cancer-targeting device in the U.S.
Mass Device
Alpha Tau Medical
clinical trials
Alpha DaRT
devices
Flag link:
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
CP Wire
Allegro
Luminate
diabetic macular edema
clinical trials
diabetes
Flag link:
Amid Immunocore’s C-suite bloodletting Glaxo provides solace
Amid Immunocore’s C-suite bloodletting Glaxo provides solace
EP Vantage
Immunocore
GSK
clinical trials
IMCnyeso
Flag link:
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Flag link:
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
Fierce Biotech
Entasis
IPOs
AstraZeneca
clinical trials
beta-lactams
Flag link:
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
CP Wire
XERIS
diabetes
artificial pancreas
devices
clinical trials
Flag link:
Catalyst gives positive hemophilia update as 2 more subjects complete study
Catalyst gives positive hemophilia update as 2 more subjects complete study
Biopharma Dive
Catalyst Bioscences
hemophilia
clinical trials
Flag link:
Realm Craters As Another Phase II Trial Fails to Reach Endpoints
Realm Craters As Another Phase II Trial Fails to Reach Endpoints
BioSpace
Realm Therapeutics
atopic dermatitis
clinical trials
PR022
Flag link:
Izana starts proof-of-concept trial for spinal arthritis drug
Izana starts proof-of-concept trial for spinal arthritis drug
Fierce Biotech
Izana
clinical trials
namilumab
ankylosing spondylitis
Flag link:
Gemphire's lead drug worsened disease, investigators conclude in ending trial
Gemphire's lead drug worsened disease, investigators conclude in ending trial
Biopharma Dive
Gemphire Therapeutics
clinical trials
NASH
Flag link:
Ampio Pharma craters on FDA setback but plans to fight back
Ampio Pharma craters on FDA setback but plans to fight back
Fierce Biotech
Ampio Pharmaceuticals
FDA
clinical trials
osteoarthritis
Ampion
Flag link:
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
RAPS.org
ASCO
FDA
cancer
oncology
clinical trials
Friends of Cancer Research
Flag link:
Far-fetched fictional pharma trial anchors new Netflix series ‘Maniac’
Far-fetched fictional pharma trial anchors new Netflix series ‘Maniac’
Fierce Pharma
clinical trials
Flag link:
RegenxBio rally fades fast after biotech reports setbacks, hospitalization in gene therapy study
RegenxBio rally fades fast after biotech reports setbacks, hospitalization in gene therapy study
Endpoints
Regenxbio
gene therapy
RGX-501
clinical trials
HoFH
Flag link:
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
CP Wire
Clovis Oncology
clinical trials
Bristol-Myers Squibb
Opdivo
ovarian cancer
Flag link:
Here's Why Acceleron Pharma Inc. Lost 10.2% in July
Here's Why Acceleron Pharma Inc. Lost 10.2% in July
Yahoo/Motley Fool
Acceleron
clinical trials
luspatercept
Flag link:
Mallinckrodt Starts Phase II Duchenne Muscular Dystrophy Study but Will They Meet Recruitment Targets?
Mallinckrodt Starts Phase II Duchenne Muscular Dystrophy Study but Will They Meet Recruitment Targets?
Xtalks
Mallinckrodt
MNK-1411
Duchenne Muscular Dystrophy
clinical trials
Flag link:
Anthem Taps Artificial Intelligence Space With Allergy Research Trial
Anthem Taps Artificial Intelligence Space With Allergy Research Trial
Forbes
Anthem
doc.ai
clinical trials
artificial intelligence
allergies
Flag link:
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Endpoints
Teva Pharmaceutical
Active Biotech
Huntington's disease
clinical trials
laquinimod
Flag link:

Pages